Skip to main content
Australian Prescriber logoLink to Australian Prescriber
. 2021 Dec 1;44(6):205. doi: 10.18773/austprescr.2021.062

Top 10 drugs 2020–21

PMCID: PMC8671012  PMID: 35002034

Table 1, Table 2 and Table 3 show the top 10 drugs for the year July 2020 – June 2021. The figures are based on PBS and RPBS prescriptions from the date of supply. The figures include prescriptions under the co-payment (non-subsidised).

Table 1. Top 10 PBS/RPBS drugs by DDD/1000 pop/day.

Drug DDD/1000 pop/day*
1. atorvastatin 76.22
2. rosuvastatin 66.54
3. perindopril 54.35
4. amlodipine 53.35
5. candesartan 34.56
6. telmisartan 34.55
7. irbesartan 29.36
8. setraline 27.42
9. metformin 26.59
10. ramipril 26.52

Table 2. Top 10 PBS/RPBS drugs by prescription counts.

Drug Prescriptions
1. rosuvastatin 14,185,361
2. atorvastatin 11,673,109
3. pantoprazole 9,299,295
4. esomeprazole 8,396,611
5. perindopril 6,890,787
6. escitalopram 5,470,158
7. metformin 5,406,768
8. sertraline 5,106,720
9. cefalexin 4,617,588
10. amlodipine 4,475,471

Table 3. Top 10 PBS/RPBS drugs by cost to government (does not include rebates).

Drug Cost to government Prescriptions
1. aflibercept $443,729,600 364,846
2. pembrolizumab $431,701,955 49,694
3. nivolumab $402,113,073 50,593
4. adalimumab $297,594,138 274,986
5. denosumab $263,487,070 963,893
6. apixaban $248,455,067 3,020,507
7. ustekinumab $246,990,067 35,554
8. ranibizumab $221,730,401 190,316
9. lenalidomide $221,365,364 40,554
10. ocrelizumab $175,644,997 10,108

DDD defined daily dose

PBS Pharmaceutical Benefits Scheme

RPBS Repatriation Pharmaceutical Benefits Scheme

* DDD/thousand population/day is a more useful measure of drug utilisation than prescription counts. It shows how many people in every thousand Australians are taking the standard dose of a drug every day. DDD includes use in combination products. The calculation is based on ABS 3101.0 – Australian Demographic Statistics for December 2020.

Source: Department of Health, December 2021. © Commonwealth of Australia


Articles from Australian Prescriber are provided here courtesy of Therapeutic Guidelines Ltd

RESOURCES